Securing injection laryngoplasty with anti-reflux valve.
Anti-reflux valve
Glottal insufficiency
Injection laryngoplasty
Laryngoscopy
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
16
02
2023
accepted:
03
04
2023
medline:
15
5
2023
pubmed:
20
4
2023
entrez:
20
04
2023
Statut:
ppublish
Résumé
Injection laryngoplasty (IL) is a common procedure performed by the laryngologist to treat glottal insufficiency. It can be performed under general anaesthesia (GA) or as an office-based procedure. One of the common problems faced during IL is the disconnection between the injection needle and injection material syringe due to high-pressure effect. This may lead to leakage of the injectates especially when injecting high-viscosity materials such as calcium hydroxylapatite (CaHa) or injecting through hard fibrotic scar of the vocal fold. Due to this recurring issue, we propose anti-reflux valve as a connector to link up these two devices. The function of anti-reflux valve is to ensure secure connection between these two devices and overcome the problem. The anti-reflux valve that can be used is NeutraClearTM needle-free connector EL-NC1000 or MicroClaveTM clear connector. In our practice, these anti-reflux valves are used together with Integra MicroFrance straight malleable injection needle (0.5 mm diameter, 250 mm length) for IL under GA. However, any other injection needle suitable for IL may also be used with these anti-reflux valves. Our 3 years' experience has shown good outcome with no reported incidence of device detachment or leakage of injectates during IL procedure. Anti-reflux valve is a readily available device in the operating theatre or clinic and only involve simple preparation prior to IL. It is beneficial as an added device in IL procedure.
Sections du résumé
BACKGROUND
BACKGROUND
Injection laryngoplasty (IL) is a common procedure performed by the laryngologist to treat glottal insufficiency. It can be performed under general anaesthesia (GA) or as an office-based procedure. One of the common problems faced during IL is the disconnection between the injection needle and injection material syringe due to high-pressure effect. This may lead to leakage of the injectates especially when injecting high-viscosity materials such as calcium hydroxylapatite (CaHa) or injecting through hard fibrotic scar of the vocal fold.
PURPOSE
OBJECTIVE
Due to this recurring issue, we propose anti-reflux valve as a connector to link up these two devices. The function of anti-reflux valve is to ensure secure connection between these two devices and overcome the problem.
METHODS
METHODS
The anti-reflux valve that can be used is NeutraClearTM needle-free connector EL-NC1000 or MicroClaveTM clear connector. In our practice, these anti-reflux valves are used together with Integra MicroFrance straight malleable injection needle (0.5 mm diameter, 250 mm length) for IL under GA. However, any other injection needle suitable for IL may also be used with these anti-reflux valves.
RESULTS
RESULTS
Our 3 years' experience has shown good outcome with no reported incidence of device detachment or leakage of injectates during IL procedure.
CONCLUSIONS
CONCLUSIONS
Anti-reflux valve is a readily available device in the operating theatre or clinic and only involve simple preparation prior to IL. It is beneficial as an added device in IL procedure.
Identifiants
pubmed: 37079073
doi: 10.1007/s00405-023-07969-z
pii: 10.1007/s00405-023-07969-z
doi:
Substances chimiques
Durapatite
91D9GV0Z28
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3027-3029Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Bruening W (1911) Uber eine neue behandlungsmethode der rekurrensslahmung. Ver Deutsch Laryng 18:93–151 (Google Scholar)
Mallur PS, Rosen CA (2010) Vocal fold injection: review of indications, techniques, and materials for augmentation. Clin Exp Otorhinolaryngol 3(4):177–182. https://doi.org/10.3342/ceo.2010.3.4.177
doi: 10.3342/ceo.2010.3.4.177
pubmed: 21217957
pmcid: 3010535
Berteau C, Filipe-Santos O, Wang T, Rojas HE, Granger C, Schwarzenbach F (2015) Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance. Med Devices (Auckl) 8:473–484. https://doi.org/10.2147/MDER.S91019 . (published 2015 Nov 11)
doi: 10.2147/MDER.S91019
pubmed: 26635489
Chhetri DK, Jamal N (2014) Percutaneous injection laryngoplasty. Laryngoscope 124(3):742–745. https://doi.org/10.1002/lary.24417
doi: 10.1002/lary.24417
pubmed: 24114620
Kamarudin N, Abdul Rahim N, Azman M et al (2022) Subchordal cyst containing non-degraded hyaluronic acid: a rare complication of injection laryngoplasty. Cureus 14(8):e27801. https://doi.org/10.7759/cureus.27801
doi: 10.7759/cureus.27801
pubmed: 36106296
pmcid: 9452055
Chhetri DK, Jahan-Parwar B, Hart SD, Bhuta SM, Berke GS (2004) Injection laryngoplasty with calcium hydroxylapatite gel implant in an in vivo canine model. Ann Otol Rhinol Laryngol 113(4):259–264
doi: 10.1177/000348940411300402
pubmed: 15112967
Tabak YP, Jarvis WR, Sun X, Crosby CT, Johannes RS (2014) Meta-analysis on central line-associated bloodstream infections associated with a needleless intravenous connector with a new engineering design. Am J Infect Control 42(12):1278–1284. https://doi.org/10.1016/j.ajic.2014.08.018 . (Epub 2014 Nov 25, PMID: 25465257)
doi: 10.1016/j.ajic.2014.08.018
pubmed: 25465257